Argonaut Technologies' Stockholders Approve Sale of Assets to Biotage


Argonaut Technologies announced that its stockholders have approved the sale of the assets of its chemistry consumables business and certain assets of its process chemistry business, which constitute substantially all of its assets except for its cash, to Biotage AB of Uppsala, Sweden. Argonaut and Biotage expect to close the transaction on June 3, 2005.

Other news from the department business & finance

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics